• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“肇事逃逸”事件——病毒驱动型癌症进展的一个可能关联。

A "hit-and-run" affair - A possible link for cancer progression in virally driven cancers.

机构信息

Menzies Health Institute Queensland, School of Medical Science, Griffith University, Southport, Queensland, Australia.

Menzies Health Institute Queensland, School of Medical Science, Griffith University, Southport, Queensland, Australia.

出版信息

Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188476. doi: 10.1016/j.bbcan.2020.188476. Epub 2020 Nov 10.

DOI:10.1016/j.bbcan.2020.188476
PMID:33186643
Abstract

BACKGROUND

It is well-known that certain cancers are caused by viruses. However, viral oncogenesis is complex and only a small fraction of the infected people develop cancer. Indeed, a number of environmental factors can contribute to virally infected cells developing cancer hallmarks, promoting tumorigenesis.

SCOPE OF REVIEW

The hit-and-run theory proposes that viruses facilitate the accumulation of mutations and promote genomic instability until the virus becomes dispensable for tumour maintenance. Indeed, several studies have reported viral genome, episome and/or oncogene loss in tumour cells without losing malignant phenotype.

MAJOR CONCLUSIONS

The current evidence supports the clear contribution of certain viruses to develop cancers. Importantly, the evidence supporting the sustained maintenance of malignancy after the loss of viral "presence" is sufficient to support the hit-and-run hypothesis of viral cancer development. Long-term tracking of vaccination outcome over the decades will test this theory.

GENERAL SIGNIFICANCE

If the hit-and-run theory is true, viruses might cause more cancers than previously thought and will have implications in the prevention of many cancers through implementing vaccination programs.

摘要

背景

众所周知,某些癌症是由病毒引起的。然而,病毒致癌作用复杂,只有一小部分感染人群会发展为癌症。事实上,许多环境因素可能会导致病毒感染细胞出现癌症特征,促进肿瘤发生。

综述范围

冲击-逃逸理论提出,病毒促进突变的积累并促进基因组不稳定,直到病毒对肿瘤维持变得可有可无。事实上,有几项研究报告了肿瘤细胞中病毒基因组、附加体和/或癌基因的丢失,而没有失去恶性表型。

主要结论

目前的证据支持某些病毒对癌症发展的明确贡献。重要的是,支持在病毒“存在”丧失后恶性持续维持的证据足以支持病毒致癌发展的冲击-逃逸假说。几十年来对疫苗接种结果的长期跟踪将检验这一理论。

一般意义

如果冲击-逃逸理论是正确的,那么病毒可能会导致比以前认为的更多的癌症,并将通过实施疫苗接种计划对许多癌症的预防产生影响。

相似文献

1
A "hit-and-run" affair - A possible link for cancer progression in virally driven cancers.“肇事逃逸”事件——病毒驱动型癌症进展的一个可能关联。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188476. doi: 10.1016/j.bbcan.2020.188476. Epub 2020 Nov 10.
2
More than just oncogenes: mechanisms of tumorigenesis by human viruses.不只是癌基因:人类病毒引发肿瘤的机制。
Curr Opin Virol. 2018 Oct;32:48-59. doi: 10.1016/j.coviro.2018.09.003. Epub 2018 Sep 27.
3
Designer nucleases to treat malignant cancers driven by viral oncogenes.设计核酸酶以治疗由病毒癌基因驱动的恶性癌症。
Virol J. 2021 Jan 13;18(1):18. doi: 10.1186/s12985-021-01488-1.
4
[Cancers, oncogenesis and oncogenes].[癌症、肿瘤发生与癌基因]
Med Trop (Mars). 1983 May-Jun;43(3):217-25.
5
Viruses associated with human cancer.与人类癌症相关的病毒。
Biochim Biophys Acta. 2008 Mar;1782(3):127-50. doi: 10.1016/j.bbadis.2007.12.005. Epub 2007 Dec 23.
6
Viral hit and run-oncogenesis: genetic and epigenetic scenarios.病毒的冲击和连续致癌:遗传和表观遗传情景。
Cancer Lett. 2011 Jun 28;305(2):200-17. doi: 10.1016/j.canlet.2010.08.007. Epub 2010 Sep 1.
7
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease.病毒致癌作用:人类疾病分子机制与病因学的揭示
Carcinogenesis. 2000 Mar;21(3):405-26. doi: 10.1093/carcin/21.3.405.
8
Viral and cellular oncogenes promote immune evasion.病毒癌基因和细胞癌基因促进免疫逃逸。
Oncogene. 2022 Feb;41(7):921-929. doi: 10.1038/s41388-021-02145-1. Epub 2022 Jan 13.
9
The p53 tumour suppressor gene.p53肿瘤抑制基因。
Nature. 1991 Jun 6;351(6326):453-6. doi: 10.1038/351453a0.
10
Evidence of a hit-and-run tumour virus.一种肇事逃逸肿瘤病毒的证据。
Nature. 1983;303(5916):383. doi: 10.1038/303383a0.

引用本文的文献

1
A landscape review with novel criteria to evaluate microbial drivers for cancer: priorities for innovative research targeting excessive cancer mortality in sub-Saharan Africa.一项采用新标准评估癌症微生物驱动因素的全景综述:针对撒哈拉以南非洲地区过高癌症死亡率的创新研究重点
Front Cell Infect Microbiol. 2025 Aug 20;15:1625818. doi: 10.3389/fcimb.2025.1625818. eCollection 2025.
2
EBV-Driven HLH and T Cell Lymphoma in a Child with X-Linked Agammaglobulinemia: A Genetically Confirmed Case Report and Literature Review.X连锁无丙种球蛋白血症患儿中的EBV驱动的噬血细胞性淋巴组织细胞增生症和T细胞淋巴瘤:一例基因确诊病例报告及文献复习
J Pers Med. 2025 Aug 9;15(8):365. doi: 10.3390/jpm15080365.
3
Differential Expression of Epstein-Barr Virus Sequences in Various Breast Cancer Subtypes.
爱泼斯坦-巴尔病毒序列在不同乳腺癌亚型中的差异表达
Genes (Basel). 2025 Jun 27;16(7):756. doi: 10.3390/genes16070756.
4
Transforming Properties of E6/E7 Oncogenes from Beta-2 HPV80 in Primary Human Fibroblasts.β-2型人乳头瘤病毒80型E6/E7癌基因在原代人成纤维细胞中的转化特性
Int J Mol Sci. 2025 Jun 2;26(11):5347. doi: 10.3390/ijms26115347.
5
JC Polyomavirus in Prostate Cancer-Friend or Foe?前列腺癌中的JC多瘤病毒:是友还是敌?
Cancers (Basel). 2025 May 21;17(10):1725. doi: 10.3390/cancers17101725.
6
Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus.由与小鼠乳腺肿瘤病毒同源的人类β逆转录病毒驱动的人类散发性乳腺癌组织类型。
Int J Cancer. 2025 Jul 15;157(2):371-383. doi: 10.1002/ijc.35438. Epub 2025 Apr 11.
7
Immune Modulation by Epstein-Barr Virus Lytic Cycle: Relevance and Implication in Oncogenesis.爱泼斯坦-巴尔病毒裂解周期的免疫调节:在肿瘤发生中的相关性及影响
Pathogens. 2024 Oct 8;13(10):876. doi: 10.3390/pathogens13100876.
8
Early growth response 1 transcription factor and its context-dependent functions in glioblastoma.早期生长反应1转录因子及其在胶质母细胞瘤中的上下文依赖性功能。
Contemp Oncol (Pozn). 2024;28(2):91-97. doi: 10.5114/wo.2024.142583. Epub 2024 Aug 23.
9
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review.释放潜能:胃癌中的爱泼斯坦-巴尔病毒(EBV)及未来治疗前景,一篇文献综述
Pathogens. 2024 Aug 28;13(9):728. doi: 10.3390/pathogens13090728.
10
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies.在过继性细胞疗法中利用肿瘤病毒衍生抗原对抗病毒性恶性肿瘤。
Biomark Res. 2024 Jul 29;12(1):71. doi: 10.1186/s40364-024-00617-6.